✦ LIBER ✦

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

✍ Scribed by Taieb, Julien; Tabernero, Josep; Mini, Enrico; Subtil, Fabien; Folprecht, Gunnar; Van Laethem, Jean-Luc; Thaler, Josef; Bridgewater, John; Petersen, Lone Nørgård; Blons, Hélène; Collette, Laurence; Van Cutsem, Eric; Rougier, Philippe; Salazar, Ramon; Bedenne, Laurent; Emile, Jean-François; Laurent-Puig, Pierre; Lepage, Come

Book ID: 125799551
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 466 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70227-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N0147: A Randomized Phase III Trial of O

N0147: A Randomized Phase III Trial of Oxaliplatin plus 5-Fluorouracil/Leucovorin with or Without Cetuximab After Curative Resection of Stage III Colon Cancer

✍ Steven R. Alberts; Frank A. Sinicrope; Axel Grothey 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

Leucovorin, fluorouracil, and oxaliplati

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

✍ Yamada, Yasuhide; Takahari, Daisuke; Matsumoto, Hiroshi; Baba, Hideo; Nakamura, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 438 KB

Cisplatin and fluorouracil with or witho

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

✍ Vermorken, Jan B; Stöhlmacher-Williams, Jan; Davidenko, Irina; Licitra, Lisa; Wi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 615 KB

Gemcitabine and capecitabine with or wit

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

✍ Middleton, Gary; Silcocks, Paul; Cox, Trevor; Valle, Juan; Wadsley, Jonathan; Pr 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 385 KB

FOXFIRE protocol: an open-label, randomi

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer

✍ Susan J Dutton,Nicola Kenealy,Sharon B Love,Harpreet S Wasan… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 333 KB

Quality of life in patients with locally

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

✍ Per Fransson; Jo-Åsmund Lund; Jan-Erik Damber; Olbjörn Klepp; Fredrik Wiklund; S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 184 KB